Form 4 for CCCC C4 Therapeutics, Inc.

Accepted 2022-10-04 00:00:00 ET · period of report 2022-10-03 · accession 0001662579-22-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-10-04	2022-10-03	CCCC	Anderson Kenneth Carl	Dir	A - Grant	$8.69	+1,150	92.8K	+1%	+$9,994
DM	2022-10-04	2022-10-03	CCCC	Anderson Kenneth Carl	Dir	M - OptEx	$3.90	+712	91.3K	+0.8%	+$2,779
DM	2022-10-04	2022-10-03	CCCC	Anderson Kenneth Carl	Dir	M - OptEx	$0.00	-712	1,334	-35%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-10-03	A	A	1,150	$8.69	92,848	D	—	—	(F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 3, 2022.
2	Common	Common Stock	2022-10-03	M	A	445	$4.98	91,698	D	—	—
3	Common	Common Stock	2022-10-03	M	A	267	$2.11	91,253	D	—	—
4	Derivative	Stock Option (Right to Buy)	2022-10-03	M	D	267	$0.00	1,335	D	$2.11 · — to 2026-07-12	267 Common Stock	(F7) 12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.
5	Derivative	Stock Option (Right to Buy)	2022-10-03	M	D	445	$0.00	1,334	D	$4.98 · — to 2030-07-02	445 Common Stock	(F8) The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020.